HRP20161626T1 - Pripravak protiv epistakse - Google Patents
Pripravak protiv epistakse Download PDFInfo
- Publication number
- HRP20161626T1 HRP20161626T1 HRP20161626TT HRP20161626T HRP20161626T1 HR P20161626 T1 HRP20161626 T1 HR P20161626T1 HR P20161626T T HRP20161626T T HR P20161626TT HR P20161626 T HRP20161626 T HR P20161626T HR P20161626 T1 HRP20161626 T1 HR P20161626T1
- Authority
- HR
- Croatia
- Prior art keywords
- gel
- concentration
- preparation according
- per liter
- glycine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0703377A GB2447012B (en) | 2007-02-21 | 2007-02-21 | Composition for combating epistaxis |
| PCT/GB2008/000608 WO2008102150A2 (en) | 2007-02-21 | 2008-02-21 | Composition for combating epistaxis |
| EP08709491.8A EP2117502B1 (en) | 2007-02-21 | 2008-02-21 | Composition for combating epistaxis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20161626T1 true HRP20161626T1 (hr) | 2017-03-10 |
Family
ID=37909023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20161626TT HRP20161626T1 (hr) | 2007-02-21 | 2008-02-21 | Pripravak protiv epistakse |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9138406B2 (enExample) |
| EP (1) | EP2117502B1 (enExample) |
| JP (1) | JP2010519285A (enExample) |
| KR (1) | KR20090130001A (enExample) |
| CN (1) | CN101677940B (enExample) |
| AU (1) | AU2008217608B2 (enExample) |
| BR (1) | BRPI0807732B8 (enExample) |
| CA (1) | CA2678706C (enExample) |
| DK (1) | DK2117502T3 (enExample) |
| ES (1) | ES2606947T3 (enExample) |
| GB (1) | GB2447012B (enExample) |
| HR (1) | HRP20161626T1 (enExample) |
| HU (1) | HUE031199T2 (enExample) |
| IL (1) | IL200277A0 (enExample) |
| PL (1) | PL2117502T3 (enExample) |
| PT (1) | PT2117502T (enExample) |
| RU (1) | RU2473327C2 (enExample) |
| WO (1) | WO2008102150A2 (enExample) |
| ZA (1) | ZA200905519B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2447012B (en) | 2007-02-21 | 2011-03-16 | Pharmacure Health Care Ab | Composition for combating epistaxis |
| USD993736S1 (en) | 2023-05-17 | 2023-08-01 | Line Work Bucket Products, LLC | Auger and socket holder |
| WO2026030821A1 (en) * | 2024-08-07 | 2026-02-12 | Conlin Anne | Nasal formulations for non-invasive nasal delivery |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4363319A (en) * | 1980-06-30 | 1982-12-14 | Applied Medical Devices, Inc. | Ready-to-use bandage incorporating a coagulant composition and method of preparing same |
| JPS63174924A (ja) * | 1987-01-14 | 1988-07-19 | Toko Yakuhin Kogyo Kk | 軟膏基剤および軟膏剤 |
| AU2793292A (en) * | 1991-10-11 | 1993-05-03 | Novo Nordisk A/S | Hemostatic composition for local hemostasis |
| CN1091315A (zh) * | 1992-10-08 | 1994-08-31 | E·R·斯奎布父子公司 | 血纤维蛋白封闭剂组合物及其使用方法 |
| US5928611A (en) * | 1995-06-07 | 1999-07-27 | Closure Medical Corporation | Impregnated applicator tip |
| US6365131B1 (en) * | 1997-10-31 | 2002-04-02 | J. B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic |
| US6818018B1 (en) * | 1998-08-14 | 2004-11-16 | Incept Llc | In situ polymerizable hydrogels |
| WO2001000218A1 (en) * | 1999-06-30 | 2001-01-04 | Scott Cordray | Nasal spray having dead sea salts |
| US20050232868A1 (en) * | 1999-10-19 | 2005-10-20 | The Procter & Gamble Company | Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions |
| US20030077301A1 (en) * | 1999-12-16 | 2003-04-24 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| RU2156612C1 (ru) * | 2000-03-13 | 2000-09-27 | Волков Александр Григорьевич | Способ остановки носового кровотечения |
| US7544348B2 (en) * | 2001-02-15 | 2009-06-09 | Access Pharmaceuticals, Inc. | Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| US7303759B2 (en) * | 2001-06-22 | 2007-12-04 | The United States Of America As Represented By The Secretary Of The Army | Compositions and methods for reducing blood and fluid loss from open wounds |
| DE10361306A1 (de) * | 2003-12-24 | 2005-07-28 | Lts Lohmann Therapie-Systeme Ag | Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür |
| CN101001649B (zh) * | 2004-07-09 | 2011-08-31 | 弗罗桑医疗设备公司 | 包括透明质酸的止血组合物及其制备方法 |
| GB2409162B (en) * | 2004-10-06 | 2005-12-14 | Bhk Holding Ltd | Materials,methods,and apparatus for treating a body cavity |
| RU2290937C1 (ru) * | 2005-10-03 | 2007-01-10 | Владислав Владимирович Петров | Способ остановки носового кровотечения |
| GB2447012B (en) | 2007-02-21 | 2011-03-16 | Pharmacure Health Care Ab | Composition for combating epistaxis |
-
2007
- 2007-02-21 GB GB0703377A patent/GB2447012B/en not_active Expired - Fee Related
-
2008
- 2008-02-21 KR KR1020097019543A patent/KR20090130001A/ko not_active Ceased
- 2008-02-21 US US12/525,975 patent/US9138406B2/en active Active
- 2008-02-21 EP EP08709491.8A patent/EP2117502B1/en active Active
- 2008-02-21 CA CA2678706A patent/CA2678706C/en active Active
- 2008-02-21 HU HUE08709491A patent/HUE031199T2/en unknown
- 2008-02-21 HR HRP20161626TT patent/HRP20161626T1/hr unknown
- 2008-02-21 PL PL08709491T patent/PL2117502T3/pl unknown
- 2008-02-21 ZA ZA200905519A patent/ZA200905519B/xx unknown
- 2008-02-21 WO PCT/GB2008/000608 patent/WO2008102150A2/en not_active Ceased
- 2008-02-21 PT PT87094918T patent/PT2117502T/pt unknown
- 2008-02-21 RU RU2009134086/15A patent/RU2473327C2/ru not_active IP Right Cessation
- 2008-02-21 JP JP2009550758A patent/JP2010519285A/ja active Pending
- 2008-02-21 BR BRPI0807732A patent/BRPI0807732B8/pt not_active IP Right Cessation
- 2008-02-21 ES ES08709491.8T patent/ES2606947T3/es active Active
- 2008-02-21 CN CN200880005428.8A patent/CN101677940B/zh not_active Expired - Fee Related
- 2008-02-21 DK DK08709491.8T patent/DK2117502T3/en active
- 2008-02-21 AU AU2008217608A patent/AU2008217608B2/en not_active Ceased
-
2009
- 2009-08-06 IL IL200277A patent/IL200277A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101677940B (zh) | 2014-02-19 |
| PT2117502T (pt) | 2016-12-13 |
| IL200277A0 (en) | 2010-04-29 |
| US20100119472A1 (en) | 2010-05-13 |
| HUE031199T2 (en) | 2017-07-28 |
| JP2010519285A (ja) | 2010-06-03 |
| KR20090130001A (ko) | 2009-12-17 |
| ZA200905519B (en) | 2010-10-27 |
| CN101677940A (zh) | 2010-03-24 |
| RU2009134086A (ru) | 2011-03-27 |
| EP2117502B1 (en) | 2016-11-09 |
| DK2117502T3 (en) | 2017-01-23 |
| CA2678706C (en) | 2014-11-18 |
| CA2678706A1 (en) | 2008-08-28 |
| ES2606947T3 (es) | 2017-03-28 |
| GB0703377D0 (en) | 2007-03-28 |
| EP2117502A2 (en) | 2009-11-18 |
| BRPI0807732A2 (pt) | 2014-06-03 |
| AU2008217608A1 (en) | 2008-08-28 |
| RU2473327C2 (ru) | 2013-01-27 |
| BRPI0807732B1 (pt) | 2020-08-04 |
| PL2117502T3 (pl) | 2017-08-31 |
| GB2447012B (en) | 2011-03-16 |
| WO2008102150A2 (en) | 2008-08-28 |
| AU2008217608B2 (en) | 2013-01-10 |
| GB2447012A (en) | 2008-09-03 |
| BRPI0807732B8 (pt) | 2021-05-25 |
| WO2008102150A3 (en) | 2009-04-30 |
| US9138406B2 (en) | 2015-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201909466T4 (tr) | Düşük serbest stearik asit içeren veya tespit edilebilen hiç serbest stearik asit içermeyen, stearik asitle işlenmiş kalsiyum karbonat bileşimleri ve ilgili yöntemler. | |
| BRPI0710485B1 (pt) | composições líquidas úteis no tratamento de doenças respiratórias | |
| TN2011000416A1 (en) | Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient | |
| NZ610346A (en) | Hyaluronic acid based formulations | |
| EP2374530A8 (en) | Foaming composition for high temperature and salinity | |
| MX354543B (es) | Composicion esterilizada que comprende al menos un acido hialuronico y ascorbilo fosfato de magnesio. | |
| MX357344B (es) | Producto para el cuidado oral y métodos de uso y fabricación del mismo. | |
| MY148948A (en) | Catecholamine derivatives and prodrugs thereof | |
| MY159630A (en) | Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof | |
| EA201070544A1 (ru) | Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений | |
| MX2009005413A (es) | Formas cristalinas del acido zoledronico. | |
| BRPI0806392A8 (pt) | uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica | |
| EP2528578A4 (en) | DENTAL COMPOSITION USING A CALCIUM SOURCE | |
| MX2011007760A (es) | Composiciones farmaceuticas que comprenden polimero vinculante a fosfato. | |
| WO2011034916A3 (en) | Bone substitute compositions, methods of preparation and clinical applications | |
| UA95224C2 (ru) | Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения | |
| MX2009013197A (es) | Derivados terapeuticos de pirazolonaftiridina. | |
| MX2009003336A (es) | Agentes policiclicos para el tratamiento de infecciones de virus sincitiales respiratorias. | |
| FI20085608A7 (fi) | Lietelannan fosforipitoisuuden alentaminen | |
| MX2012001178A (es) | Composicion que consta de un material polimerico anionico y la sal de un acido monocarboxilico saturado que tiene 6 a 22 atomos de carbono. | |
| WO2008022859A3 (de) | Zusammensetzung enthaltend schwer wasserlösliche calciumsalze und/oder deren kompositmaterialien in einer menge von 1 bis 99 gew.-% | |
| DE602007010029D1 (enExample) | ||
| JP2019529559A5 (enExample) | ||
| WO2008102150A3 (en) | Composition for combating epistaxis | |
| EA200802262A1 (ru) | Назальные и буккальные композиции для борьбы с храпом |